Starting once-weekly insulin for type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a new once-weekly insulin called Icodec for people with type 2 diabetes. It looks at the best way to start using it, including a possible extra dose on day 4, to help control blood sugar safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have type 2 diabetes for at least 6 months.
- You haven't used insulin in the past 3 months.
- You take at least one diabetes pill or non-insulin injection, but your blood sugar is still not well controlled.
- Your HbA1c (average blood sugar) is between 7% and 11%.
- Your body mass index (BMI) is 35 or lower.
- You are willing to wear a continuous glucose monitor and attend study visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a once-weekly injection (HDM1005) to see if it improves blood sugar control in people with type 2 diabetes who are already taking metformin alone or with an SGLT2 inhibitor. It may help lower your A1C levels and manage your weight.
This study tests a new once-weekly injectable medication (HDM1005) for people with type 2 diabetes whose blood sugar is not well controlled by diet and exercise or metformin alone. It aims to help lower blood sugar and may also support weight loss.
This study tests a new once-daily insulin (GZR4) against an approved insulin (degludec) in people with type 2 diabetes to see how well it controls blood sugar. You may qualify if you are already using a stable dose of background insulin.
This study looks at what happens when people with type 2 diabetes switch from a short course of intensive insulin therapy to different daily diabetes medicines. It aims to find which option helps keep blood sugar under control and might be easier for you.
This study compares two ways of tracking blood sugar in people with type 2 diabetes who use insulin. It aims to see if one method helps manage glucose better, which could improve daily control and long-term health.
This study tests whether switching from daily basal insulin to once-weekly insulin icodec improves blood sugar control, treatment satisfaction, and how well people stick with the new insulin. It may be a good option if you have type 2 diabetes and are already using a daily basal insulin.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.